These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20153352)

  • 41. Recommended composition of influenza virus vaccines for use in the 2017 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Oct; 91(41):469-84. PubMed ID: 27758094
    [No Abstract]   [Full Text] [Related]  

  • 42. Recommended composition of influenza virus vaccines for use in the 2011-2012 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2011 Mar; 86(10):86-90. PubMed ID: 21395187
    [No Abstract]   [Full Text] [Related]  

  • 43. Recommended composition of influenza virus vaccines for use in the 2014 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2013 Oct; 88(41):437-48. PubMed ID: 24159667
    [No Abstract]   [Full Text] [Related]  

  • 44. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results.
    Pebody RG; Warburton F; Ellis J; Andrews N; Thompson C; von Wissmann B; Green HK; Cottrell S; Johnston J; de Lusignan S; Moore C; Gunson R; Robertson C; McMenamin J; Zambon M
    Euro Surveill; 2015 Feb; 20(5):21025. PubMed ID: 25677050
    [No Abstract]   [Full Text] [Related]  

  • 45. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.
    Fielding JE; Grant KA; Papadakis G; Kelly HA
    BMC Infect Dis; 2011 Jun; 11():170. PubMed ID: 21669006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
    de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The rationale for quadrivalent influenza vaccines.
    Ambrose CS; Levin MJ
    Hum Vaccin Immunother; 2012 Jan; 8(1):81-8. PubMed ID: 22252006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2017 Mar; 92(11):117-28. PubMed ID: 28303704
    [No Abstract]   [Full Text] [Related]  

  • 49. Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season (northern hemisphere winter).
    Wkly Epidemiol Rec; 2009 Feb; 84(9):65-72. PubMed ID: 19248288
    [No Abstract]   [Full Text] [Related]  

  • 50. Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016.
    Havlickova M; Druelles S; Jirincova H; Limberkova R; Nagy A; Rasuli A; Kyncl J
    BMC Infect Dis; 2019 Feb; 19(1):160. PubMed ID: 30764763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recommended composition of influenza vaccines for use in the 2012 southern hemisphere influenza season.
    Wkly Epidemiol Rec; 2011 Oct; 86(42):457-68. PubMed ID: 22046594
    [No Abstract]   [Full Text] [Related]  

  • 52. Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013.
    Mosnier A; Caini S; Daviaud I; Bensoussan JL; Stoll-Keller F; Bui TT; Lina B; Van der Werf S; Cohen JM;
    BMC Infect Dis; 2015 Aug; 15():357. PubMed ID: 26289794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influenza virus infections from 0 to 2 years of age: A birth cohort study.
    Teros-Jaakkola T; Toivonen L; Schuez-Havupalo L; Karppinen S; Julkunen I; Waris M; Peltola V
    J Microbiol Immunol Infect; 2019 Aug; 52(4):526-533. PubMed ID: 29254653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influenza surveillance in five consecutive seasons during post pandemic period: results from National Influenza Center, Turkey].
    Altaş AB; Bayrakdar F; Korukluoğlu G
    Mikrobiyol Bul; 2016 Jul; 50(3):401-17. PubMed ID: 27525396
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late season interim estimates of influenza vaccine effectiveness reliably predict end of season estimates in Victoria, Australia, 2007 to 2012.
    Sullivan SG; Kelly H
    Euro Surveill; 2013 Oct; 18(41):20605. PubMed ID: 24135124
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-MOVE multicentre case-control study, 2012/13.
    Valenciano M; Kissling E;
    Euro Surveill; 2013 Feb; 18(7):3. PubMed ID: 23449183
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recommended composition of influenza virus vaccines for use in the 2007-2008 influenza season.
    Wkly Epidemiol Rec; 2007 Mar; 82(9):69-74. PubMed ID: 17333570
    [No Abstract]   [Full Text] [Related]  

  • 58. Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.
    McVernon J; Laurie K; Barr I; Kelso A; Skeljo M; Nolan T
    Influenza Other Respir Viruses; 2011 Jan; 5(1):7-11. PubMed ID: 21138535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Debate on the compositions of influenza B in northern hemisphere seasonal influenza vaccines.
    He G; Yang P; Yan Q; Xiong C
    Antimicrob Resist Infect Control; 2019; 8():164. PubMed ID: 31673353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Live attenuated seasonal and pandemic influenza vaccine in school-age children: a randomized controlled trial.
    Klick B; Durrani S; Chan KH; Ip DK; Chou ES; Kwok HK; Ng S; Chiu SS; Peiris JS; Leung GM; Cowling BJ
    Vaccine; 2013 Apr; 31(15):1937-43. PubMed ID: 23434387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.